14.56
+0.02
+(0.14%)
At close: January 31 at 4:25:00 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
7,171.00
24,430.00
58,368.00
74,970.00
46,739.00
Investing Cash Flow
-14,383.00
-21,015.00
-33,195.00
-11,564.00
64,851.00
Financing Cash Flow
-1,841.00
-1,316.00
-1,924.00
-3,160.00
-3,074.00
End Cash Position
170,016.00
180,894.00
178,795.00
200,424.00
140,178.00
Capital Expenditure
-15,222.00
-19,219.00
-12,432.00
-11,598.00
-1,912.00
Issuance of Capital Stock
2,023.00
2,584.00
1,600.00
1,600.00
--
Free Cash Flow
-8,051.00
5,211.00
45,936.00
63,372.00
44,827.00
12/31/2020 - 11/4/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLBIO.ST Corline Biomedical AB
9.42
+1.73%
PCIB.OL PCI Biotech Holding ASA
1.2500
+2.12%
DIABIO.ST Diagonal Bio AB (publ)
0.0189
-5.50%
NYKD.OL Nykode Therapeutics AS
2.6820
+1.98%
OTLC Oncotelic Therapeutics, Inc.
0.0303
+8.21%
ACE.ST Ascelia Pharma AB (publ)
2.9150
+1.92%
CAMX.ST Camurus AB (publ)
596.00
-0.17%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
30.60
+2.00%
NAMS NewAmsterdam Pharma Company N.V.
22.29
+2.39%
APRE Aprea Therapeutics, Inc.
3.9100
+0.51%